Anesiva Inc (ANSVQ1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO, CA 94080

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management. It has two products in clinical development, which include Zingo and 4975. Zingo is an anesthetic that has completed two Phase 3 trials in the pediatric population for the treatment of pain associated with venipuncture and cannulation; and 4975 is an anesthetic for the treatment of site-specific moderate to severe pain, and is in multiple Phase 2 and Phase 3 trials in post-surgical and musculoskeletal pain.

View SEC Filings from ANSVQ1 instead.

View recent insider trading info

Funds Holding ANSVQ1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ANSVQ1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ALTA PARTNERS VIII, L.P.

NOHRA GUY P

CHAMPSI FARAH

GRUENER GARRETT

ALTA PARTNERS MANAGEMENT VIII, LLC

ALTA CALIFORNIA PARTNERS III LP

ALTA EMBARCADERO PARTNERS III LLC

  • 10% Owner
6,291,995 2010-01-06 0

JANNEY DANIEL

  • Director
  • 10% Owner
6,291,995 2010-01-06 0

TRAN JOHN H. VICE PRESIDENT, FINANCE

  • Officer
0 2009-05-07 0

HAMILTON JOHN F

  • Director
0 2009-02-12 0

HOUGHTON WILLIAM C CHIEF MEDICAL OFFICER

  • Officer
0 2008-12-03 0

VIRET JEAN-FREDERIC VP AND CHIEF FINANCIAL OFFICER

  • Officer
0 2008-12-03 0

KRANDA MICHAEL L PRESIDENT AND CEO

  • Officer
  • Director
0 2008-12-03 0

DONAHUE NANCY E SR. VP, MARKETING & SALES

  • Officer
22,651 2008-10-14 0

CAMPBELL JAMES N

  • Director
118,000 2008-09-08 0

NASH H RONALD

  • 10% Owner
No longer subject to file 2008-06-25 0

CVCA, LLC

  • 10% Owner
3,369,029 2008-05-13 0

FERGUSON RODNEY A

  • Director
3,369,063 2008-05-13 0

POWELL MICHAEL

  • Director
  • 10% Owner
4,907,038 2008-05-09 0

ECKERT CARTER H

  • Director
13,258 2008-05-09 0

ORONSKY ARNOLD L

  • Director
  • 10% Owner
4,806,917 2008-05-09 0

ZERBE ROBERT L MD

  • Director
0 2008-05-09 0

COLLIGAN THOMAS J

  • Director
2,500 2008-05-09 0

HARPER JAMES A

  • Director
9,030 2008-05-09 0

MCLAUGHLIN JOHN PETER CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
128,024 2008-02-07 0

BRODERICK PATRICK A VP & GENERAL COUNSEL

  • Officer
16,460 2008-02-06 0

REGAN JOHN X. SR. VP OPERATIONS

  • Officer
16,318 2008-02-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments